Phone
Address
ZhengZhou (HQ), Shenzhen (R&D Center), Suzhou (R&D Center), China
The approximate 50% of prostate cancers has fusion mutations, and TMPRSS2 ERG is the most common fusion gene. It is closely related to the aggressiveness and prognosis of prostate cancer. The EGR positive patients tend to have a higher stage of prostate cancer, a higher rate of recurrence, and a higher rate of pelvic lymph node metastasis.
Esophagus tissue stained with ERG
CODE |
WORKING SOLUTION |
CONCENTRATED SOLUTION |
||||
CER-0071 |
SPECIFICATION |
1ml |
3ml |
6ml |
0.1ml |
0.2ml |
Clone: C12A8
Source: Rabbit
Localization: Nucleus
Pretreatment: Thermal remediation
Applicable tissue: Paraffin section